UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 623

Sortiert nach

Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis

Nature communications, 2017-10, Vol.8 (1), p.1130-16, Article 1130

2017

Volltextzugriff (PDF)

Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis

Annals of the rheumatic diseases, 2016-05, Vol.75 (5), p.883-890

2016

Volltextzugriff (PDF)

Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis

Annals of the rheumatic diseases, 2017-11, Vol.76 (11), p.1941

2017

Volltextzugriff (PDF)

Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2020-01, Vol.72 (1), p.137-149

2020

Volltextzugriff (PDF)

Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells

Nature medicine, 2017-08, Vol.23 (8), p.938-944

2017

Volltextzugriff (PDF)

09 Lessons from scleroderma: treatment of interstitial lung disease in SLE

Lupus science & medicine, 2021-04, Vol.8 (Suppl 1), p.A5-A5

Distler, Oliver

2021

Volltextzugriff (PDF)

Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis

Nature reviews. Rheumatology, 2019-05, Vol.15 (5), p.288-302

2019

Volltextzugriff (PDF)

The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis

Nature communications, 2018-08, Vol.9 (1), p.3259-17, Article 3259

2018

Volltextzugriff (PDF)

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

Annals of the rheumatic diseases, 2021-02, Vol.80 (2), p.143

2021

Volltextzugriff (PDF)

The AP1 Transcription Factor Fosl2 Promotes Systemic Autoimmunity and Inflammation by Repressing Treg Development

Cell reports (Cambridge), 2020-06, Vol.31 (13), p.107826, Article 107826

2020

Volltextzugriff (PDF)

Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies

Annals of the rheumatic diseases, 2015-08, Vol.74 (8), p.1621-1625

2015

Volltextzugriff (PDF)

Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2017-02, Vol.69 (2), p.257-267

2017

Volltextzugriff (PDF)

Harnessing the multifunctionality of lipid-based drug delivery systems for the local treatment of osteoarthritis

Biomedicine & pharmacotherapy, 2023-12, Vol.168, p.115819-115819, Article 115819

2023

Volltextzugriff (PDF)

Platelet-derived serotonin links vascular disease and tissue fibrosis

The Journal of experimental medicine, 2011-05, Vol.208 (5), p.961-972

2011

Volltextzugriff (PDF)

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

The European respiratory journal, 2017-08, Vol.50 (2), p.1700740-1700740

2017

Volltextzugriff (PDF)

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

Arthritis research & therapy, 2021-07, Vol.23 (1), p.1-204, Article 204

2021

Volltextzugriff (PDF)

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

Annals of the rheumatic diseases, 2014-07, Vol.73 (7), p.1340-1349

2014

Volltextzugriff (PDF)

Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis

Annals of the rheumatic diseases, 2013-04, Vol.72 (4), p.614-620

2013

Volltextzugriff (PDF)

Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice

Rheumatology (Oxford, England), 2015-08, Vol.54 (8), p.1454-1458

2015

Volltextzugriff (PDF)

Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis

Annals of the rheumatic diseases, 2018-05, Vol.77 (5), p.744

2018

Volltextzugriff (PDF)

Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: Machine learning on proteomics from the DETECT cohort

The European respiratory journal, 2021-06, Vol.57 (6), p.2002591

2021

Volltextzugriff (PDF)

Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects

Respiratory research, 2022-07, Vol.23 (1), p.1-178, Article 178

2022

Volltextzugriff (PDF)

Tie2 as a novel key factor of microangiopathy in systemic sclerosis

Arthritis research & therapy, 2017-05, Vol.19 (1), p.105-105, Article 105

2017

Volltextzugriff (PDF)

Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis

The FASEB journal, 2008-07, Vol.22 (7), p.2214-2222

2008

Volltextzugriff (PDF)

Author Correction: Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis

Nature communications, 2021-12, Vol.12 (1), p.7259-7259, Article 7259

2021

Volltextzugriff (PDF)

1 – 25 von 623

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(556)
Mit Volltextzugriff
(535)

Publikationsform

Sprache

Englisch
(616)
Japanisch
(108)
Deutsch
(6)
Norwegisch
(4)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(476)
Life Sciences & Biomedicine
(455)
Humans
(348)
Rheumatology
(312)
Systemic Sclerosis
(171)
Male
(162)
Female
(159)
Scleroderma
(140)
Middle Aged
(137)
Adult
(120)
Animals
(115)
Aged
(93)
Fibrosis
(89)
Mice
(88)
Biological And Medical Sciences
(85)
Medical Sciences
(85)
Scleroderma, Systemic - Complications
(82)
Fibroblasts
(77)
Scleroderma, Systemic - Pathology
(72)
Scleroderma, Systemic - Metabolism
(64)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis

Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis

Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis

Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis

Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells

09 Lessons from scleroderma: treatment of interstitial lung disease in SLE

Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis

The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

The AP1 Transcription Factor Fosl2 Promotes Systemic Autoimmunity and Inflammation by Repressing Treg Development

Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies

Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis

Harnessing the multifunctionality of lipid-based drug delivery systems for the local treatment of osteoarthritis

Platelet-derived serotonin links vascular disease and tissue fibrosis

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis

Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice

Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis

Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: Machine learning on proteomics from the DETECT cohort

Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects

Tie2 as a novel key factor of microangiopathy in systemic sclerosis

Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis

Author Correction: Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis

Suchergebnisse filtern